Eric Obscherning

Senior Consultant

eobscherning@crowell.com

Eric Obscherning is a senior consultant at C&M International where he supports the firm’s global health practice, advising Fortune 100 biopharmaceutical and medical device companies and their trade associations as they enter emerging markets, navigate policies and regulations, and develop strategic initiatives and public-private partnerships. He works at the intersection of business strategy, public policy, and government affairs on issues related to life sciences innovation, rare diseases, vaccines confidence, healthcare financing, HPV and cervical cancer, tuberculosis, antimicrobial resistance, and regulatory harmonization.

Prior to joining C&M International, Eric was a consultant with Manchester Trade, involved in corporate social responsibility at GlobalGiving, and an early employee of an aquaponics startup. His written work has appeared in Governance in an Emerging New World (Hoover Institution Press), Climate Change & Public Health (Oxford University Press), Journal of the American Medical Association, and Global Heart. He received a BS in biology and English and a Certificate in Global Health from the University of Wisconsin-Madison, and studied NCDs and precision medicine at the U.S. National Institutes of Health.

Education

University of Wisconsin – Madison, B.S. biology and English

University of Wisconsin – Madison, Certificate global health

American University Washington College of Law, Certificate WTO and U.S. trade law and policy

U.S. National Institutes of Health, Foundation for Advanced Education in the Sciences

Publications

 

Client Alerts & Newsletters

Practice Areas

Practice Areas

  • Health Care
  • Pharmaceutical Industry & Prescription Drugs
  • International Government Affairs and Regulatory Policy
  • WTO, FTAs & Market Access

Practice Areas

  • Health Care
  • Pharmaceutical Industry & Prescription Drugs
  • International Government Affairs and Regulatory Policy
  • WTO, FTAs & Market Access